tiprankstipranks

William Bertrand Insider Profile

4 Followers
William Bertrand, General Counsel at Infinity Pharmaceuticals, holds 229.77K shares in Ardelyx (Ticker: ARDX), holds 20.20K shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 7.50K shares in Infinity Pharmaceuticals (Ticker: INFIQ).
tipranks
William Bertrand

William Bertrand
Infinity Pharmaceuticals (INFIQ)
General Counsel

Ranked #66,746 out of 99,635 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-20.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
98.91%
1.08%
<0.01%
A breakdown of William Bertrand's holdings

Insider Roles

Ardelyx
(ARDX)
Director
Adaptimmune Therapeutics
(ADAP)
COO
Infinity Pharmaceuticals
(INFIQ)
General Counsel
Roles that William Bertrand holds in companies

Most Profitable Insider Trade

Stock:
Adaptimmune Therapeutics
(ADAP)
Rating:Informative Buy
Date:Dec 15, 2020 - Dec 15, 2021
Return:-9.50%
The most profitable trade made by William Bertrand

William Bertrand's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Infinity Pharmaceuticals
Oct 20, 2015
General Counsel
Uninformative Buy
$120.00
Adaptimmune Therapeutics
Jan 17, 2024
COO
Uninformative Sell
16.37K
$13.35K
SLXP
Salix
Apr 03, 2015
Uninformative Sell
4.89M
Ardelyx
Jun 17, 2024
Director
Uninformative Buy
$1.22M
SNTS
Santarus
List of latest transactions for each holding click on a transaction to see William Bertrand's performance on stock

William Bertrand insider profile FAQ

What is the percentage of profitable transactions made by William Bertrand?
The percentage of profitable transactions made by William Bertrand is 0%.
    What is the average return per transaction made by William Bertrand?
    The average return per transaction made by William Bertrand is -20.50%.
      What stocks does William Bertrand hold?
      William Bertrand holds: INFIQ, ADAP, SLXP, ARDX, SNTS stocks.
        What was William Bertrand’s latest transaction?
        William Bertrand latest transaction was an Uninformative Buy of ―.
          What was William Bertrand's most profitable transaction?
          William Bertrand’s most profitable transaction was an Informative Buy of ADAP stock on December 15, 2020. The return on the trade was -9.50%.
            What is William Bertrand's role in Infinity Pharmaceuticals?
            William Bertrand's role in Infinity Pharmaceuticals is General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.